S&P 500   3,395.15 (-2.03%)
DOW   27,646.97 (-2.43%)
QQQ   280.56 (-1.47%)
AAPL   114.07 (-0.84%)
MSFT   210.25 (-2.77%)
FB   279.16 (-1.98%)
GOOGL   1,590.64 (-2.59%)
AMZN   3,204.51 (+0.00%)
TSLA   417.61 (-0.72%)
NVDA   532.04 (-2.13%)
BABA   305.98 (-1.27%)
CGC   18.72 (-5.12%)
GE   7.40 (-3.01%)
MU   51.85 (-1.89%)
AMD   82.15 (+0.23%)
T   27.19 (-2.26%)
F   8.06 (-1.23%)
ACB   4.42 (-5.56%)
GILD   59.49 (-2.14%)
NFLX   483.26 (-1.03%)
NIO   26.38 (-2.87%)
BA   161.37 (-3.58%)
DIS   124.55 (-2.96%)
S&P 500   3,395.15 (-2.03%)
DOW   27,646.97 (-2.43%)
QQQ   280.56 (-1.47%)
AAPL   114.07 (-0.84%)
MSFT   210.25 (-2.77%)
FB   279.16 (-1.98%)
GOOGL   1,590.64 (-2.59%)
AMZN   3,204.51 (+0.00%)
TSLA   417.61 (-0.72%)
NVDA   532.04 (-2.13%)
BABA   305.98 (-1.27%)
CGC   18.72 (-5.12%)
GE   7.40 (-3.01%)
MU   51.85 (-1.89%)
AMD   82.15 (+0.23%)
T   27.19 (-2.26%)
F   8.06 (-1.23%)
ACB   4.42 (-5.56%)
GILD   59.49 (-2.14%)
NFLX   483.26 (-1.03%)
NIO   26.38 (-2.87%)
BA   161.37 (-3.58%)
DIS   124.55 (-2.96%)
S&P 500   3,395.15 (-2.03%)
DOW   27,646.97 (-2.43%)
QQQ   280.56 (-1.47%)
AAPL   114.07 (-0.84%)
MSFT   210.25 (-2.77%)
FB   279.16 (-1.98%)
GOOGL   1,590.64 (-2.59%)
AMZN   3,204.51 (+0.00%)
TSLA   417.61 (-0.72%)
NVDA   532.04 (-2.13%)
BABA   305.98 (-1.27%)
CGC   18.72 (-5.12%)
GE   7.40 (-3.01%)
MU   51.85 (-1.89%)
AMD   82.15 (+0.23%)
T   27.19 (-2.26%)
F   8.06 (-1.23%)
ACB   4.42 (-5.56%)
GILD   59.49 (-2.14%)
NFLX   483.26 (-1.03%)
NIO   26.38 (-2.87%)
BA   161.37 (-3.58%)
DIS   124.55 (-2.96%)
S&P 500   3,395.15 (-2.03%)
DOW   27,646.97 (-2.43%)
QQQ   280.56 (-1.47%)
AAPL   114.07 (-0.84%)
MSFT   210.25 (-2.77%)
FB   279.16 (-1.98%)
GOOGL   1,590.64 (-2.59%)
AMZN   3,204.51 (+0.00%)
TSLA   417.61 (-0.72%)
NVDA   532.04 (-2.13%)
BABA   305.98 (-1.27%)
CGC   18.72 (-5.12%)
GE   7.40 (-3.01%)
MU   51.85 (-1.89%)
AMD   82.15 (+0.23%)
T   27.19 (-2.26%)
F   8.06 (-1.23%)
ACB   4.42 (-5.56%)
GILD   59.49 (-2.14%)
NFLX   483.26 (-1.03%)
NIO   26.38 (-2.87%)
BA   161.37 (-3.58%)
DIS   124.55 (-2.96%)
Log in
NASDAQ:AVGR

Avinger Stock Forecast, Price & News

$0.28
-0.01 (-2.72 %)
(As of 10/26/2020 11:30 AM ET)
Add
Compare
Today's Range
$0.28
Now: $0.28
$0.29
50-Day Range
$0.29
MA: $0.34
$0.43
52-Week Range
$0.24
Now: $0.28
$1.63
Volume29,562 shs
Average Volume5.32 million shs
Market Capitalization$24.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.7
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Read More
Avinger logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900
Employees74

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.13 million
Book Value$0.67 per share

Profitability

Net Income$-19,450,000.00
Net Margins-225.26%

Miscellaneous

Market Cap$24.02 million
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
$0.28
-0.01 (-2.72 %)
(As of 10/26/2020 11:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avinger (NASDAQ:AVGR) Frequently Asked Questions

How has Avinger's stock price been impacted by COVID-19 (Coronavirus)?

Avinger's stock was trading at $0.43 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVGR stock has decreased by 34.6% and is now trading at $0.2814.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Avinger?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Avinger
.

When is Avinger's next earnings date?

Avinger is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Avinger
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) announced its quarterly earnings data on Thursday, July, 30th. The medical device company reported ($0.18) EPS for the quarter. The medical device company earned $1.47 million during the quarter. Avinger had a negative return on equity of 283.92% and a negative net margin of 225.26%.
View Avinger's earnings history
.

When did Avinger's stock split? How did Avinger's stock split work?

Shares of Avinger reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for AVGR?

2 brokers have issued 12 month price objectives for Avinger's shares. Their forecasts range from $1.00 to $1.00. On average, they expect Avinger's share price to reach $1.00 in the next year. This suggests a possible upside of 255.4% from the stock's current price.
View analysts' price targets for Avinger
.

Are investors shorting Avinger?

Avinger saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 539,500 shares, a decline of 78.3% from the September 15th total of 2,490,000 shares. Based on an average daily volume of 12,260,000 shares, the days-to-cover ratio is currently 0.0 days.
View Avinger's Short Interest
.

Who are some of Avinger's key competitors?

What other stocks do shareholders of Avinger own?

Who are Avinger's key executives?

Avinger's management team includes the following people:
  • Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 58, Pay $521.16k)
  • Mr. Mark B. Weinswig, Chief Financial Officer (Age 47, Pay $374.45k)
  • Mr. Himanshu N. Patel, Chief Technology Officer (Age 60, Pay $369.43k)
  • Mr. Keith Schaefer, Chief Operating Officer

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by many different retail and institutional investors. Top institutional investors include Spectrum Asset Management Inc. NB CA (0.94%). Company insiders that own Avinger stock include Himanshu Patel, Jeffrey M Soinski and Mark Weinswig.
View institutional ownership trends for Avinger
.

Which major investors are buying Avinger stock?

AVGR stock was purchased by a variety of institutional investors in the last quarter, including Spectrum Asset Management Inc. NB CA.
View insider buying and selling activity for Avinger
.

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.28.

How big of a company is Avinger?

Avinger has a market capitalization of $23.90 million and generates $9.13 million in revenue each year. The medical device company earns $-19,450,000.00 in net income (profit) each year or ($3.18) on an earnings per share basis. Avinger employs 74 workers across the globe.

What is Avinger's official website?

The official website for Avinger is www.avinger.com.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.